http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2013126485-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39558 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-3955 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-517 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439 |
| filingDate | 2011-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2014-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2013126485-A |
| titleOfInvention | USE OF UREA 2-CARBOXAMIDE-CYCLOAMINO DERIVATIVES IN TREATMENT OF EGFR-DEPENDENT DISEASES OR DISEASES WITH ACQUIRED RESISTANCE TO E-MEMBER MEMBERS |
| abstract | 1. The use of a compound of formula I, or a salt thereof, wherein A is heteroaryl, which is selected from the group consisting of R, is one of the following substituents: (1) unsubstituted or substituted, preferably substituted CC-alkyl, with said substituents independently selected from one or more than one functional residue, preferably from the following residues in an amount of from one to nine: deuterium, fluorine, or from the following residues from one to two C-C-cycloalkyl; (2) optionally substituted C-C-cycloalkyl, wherein said substituents are independently selected from one or more functional residues, preferably from one to four of the following: deuterium, C-C alkyl (preferably methyl), fluoro, cyano, aminocarbonyl; (3) optionally substituted phenyl, wherein said substituents are independently selected from one or more functional residues, preferably from one to two of the following residues: deuterium, halogen, cyano, CC-alkyl, CC-alkylamino, di (CC- alkyl) amino, CC-alkylaminocarbonyl, di (CC-alkyl) aminocarbonyl, CC-alkoxy; (4) optionally mono- or disubstituted amines, wherein said substituents are independently selected from the following functional residues: deuterium, CC-alkyl (which is unsubstituted or substituted by one or more substituents selected from the group of deuterium, fluorine, chlorine, hydroxy), phenylsulfonyl (which is unsubstituted or substituted by one or more, preferably one CC-alkyl, CC-alkoxy, di (CC-alkyl) amino-CC-alkoxy); (5) substituted sulfonyl, wherein said substituent is selected from |
| priorityDate | 2010-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 78.